Schedule 13G ownership disclosure

Melinta Therapeutics Inc

Security class unavailable · CUSIP: 58549G100

Event date: 2018-01-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,313,702
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-001866
Form type
SC 13G
Filer
MEDICINES CO /DE
CIK
CIK 1113481
Filed
Jan 11, 2018
Reporting period
Jan 05, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub